Google Alert - in

	in As-it-happens update ⋅ 19 November 2020
	WEB
	Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All ... Investors@biontech.de - BioNTech In addition, the companies announced that the safety milestone required by the U.S. Food and Drug Administration (FDA) for Emergency Use ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis